Arnaud Chambellan

Design of PROGRESSION-IPF: A pragmatic, open-label, randomized trial of patients with progressive disease in idiopathic pulmonary fibrosis

Vincent Cottin, Bruno Crestani, Carole Planès, Arnaud Chambellan et autres

BACKGROUND: Idiopathic pulmonary fibrosis (IPF) is a progressive fibrotic interstitial lung disease with poor prognosis. Although antifibrotic therapies such as pirfenidone and nintedanib slow lung function decline, optimal management of patients with progression despite treatment remains undefined. Evidence-based guidance for continuation, switching, …

fr (code pays fourni par la source)

Description préliminaire d’une cohorte de 1164 EFX pour COVID long

David Debeaumont, F. Rannou, Y. Martinat, I. Guerreiro et autres

fr, ch, be (code pays fourni par la source)

Thoracentesis: an old story and some new sources

Emmanuel Drouin, É. Wiel, Édouard Lansiaux, Jacalyn M. Duffin et autres

fr, ca (code pays fourni par la source)

Fatal dyspnoea at the Palace of Versailles

Emmanuel Drouin, Serge Wasersztrum, Arnaud Chambellan

fr, us (code pays fourni par la source)

Assessing Functional Capacity in Directly and Remotely Monitored Home-Based Settings in Individuals With Chronic Respiratory Diseases: Protocol for a Multinational Validation Study

Alec Bass, Sarah Géphine, Mickaël Martin, Marianne Belley et autres

BACKGROUND: Pulmonary rehabilitation is widely recommended to improve functional status and as secondary and tertiary prevention in individuals with chronic pulmonary diseases. Unfortunately, access to timely and appropriate rehabilitation remains limited. To help close this inaccessibility gap, telerehabilitation has been proposed. However, …

ca, fr (code pays fourni par la source)

Assessing Functional Capacity in Directly and Remotely Monitored Home-Based Settings in Individuals With Chronic Respiratory Diseases: Protocol for a Multinational Validation Study (Preprint)

Alec Bass, Sarah Géphine, Mickaël Martin, Marianne Belley et autres

BACKGROUND Pulmonary rehabilitation is widely recommended to improve functional status and as secondary and tertiary prevention in individuals with chronic pulmonary diseases. Unfortunately, access to timely and appropriate rehabilitation remains limited. To help close this inaccessibility gap, telerehabilitation has been proposed. However, …

ca, fr (code pays fourni par la source)

Suivi des patients atteints de fibrose pulmonaire idiopathique par oscillométrie d’impulsion (étude OSCILLO)

P. Tossan, Plamen Bokov, Betsega Assefa Bayeh, Arnaud Chambellan et autres

fr (code pays fourni par la source)

activAnalyzer: An R Shiny app to analyse ActiGraph accelerometer data and to implement the use of the PROactive Physical Activity in COPD instruments

Pierre‐Yves de Müllenheim, Arnaud Chambellan

de Müllenheim et al., (2022). activAnalyzer: An R Shiny app to analyse ActiGraph accelerometer data and to implement the use of the PROactive Physical Activity in COPD instruments. Journal of Open Source Software, 7(80), 4741, https://doi.org/10.21105/joss.04741

fr (code pays fourni par la source)

Use of FeNO to predict anti-IL-5 and IL-5R biologics efficacy in a real-world cohort of adults with severe eosinophilic asthma

Charlotte Ménigoz, Stéphanie Dirou, Arnaud Chambellan, Dorian Hassoun et autres

Introduction Severe eosinophilic asthma (SEA) is associated with multiple exacerbations. Fractional exhaled nitric oxide (FeNO), a biomarker of airway T2 inflammation, is known to be correlated with the risk of exacerbations. While the use of FeNO is well established to predict the …

fr (code pays fourni par la source)

Laennecs’ mediate auscultation: Child's play

Emmanuel Drouin, Arnaud Chambellan

fr (code pays fourni par la source)

The first historical description of malignant mesotheliomas

Emmanuel Drouin, Arnaud Chambellan, Camille Munck, Patrick Hautecœur

fr (code pays fourni par la source)

activAnalyzer : une application pour faciliter l’accès à la mesure de l’activité physique et l’utilisation des questionnaires PROactive à partir de l’accéléromètre ActiGraph® dans la BPCO

Pierre-Yves de Müllenheim, Florian Congnard, Bénédicte Noury-Desvaux, Nicolas Masson et autres

International audience